Assessment of Formulation Factors on the Release Behaviour of BCS Class II Drug from Tablet Dosage form Using DoE

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|11|4|511-520

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.11, Iss.4, 2014-06, pp. : 511-520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design

By Duque Marcelo Dutra  

Pharmaceutical Development and Technology, Vol. 18, Iss. 5, 2013-10 ,pp. : 1247-1254

Informa Healthcare

Access to resources Recommend Favorite

Formulation and In vitro assessment of sustained release terbutaline sulfate tablet made from binary hydrophilic polymer mixtures

By Al-Akayleh Faisal  

Pharmaceutical Development and Technology, Vol. 18, Iss. 5, 2013-10 ,pp. : 1204-1212

Informa Healthcare

Access to resources Recommend Favorite

Compression of coated drug beads for sustained release tablet of glipizide: formulation, and dissolution

By Nguyen Chien   Christensen J. Mark   Ayres James W.  

Pharmaceutical Development and Technology, Vol. 19, Iss. 1, 2014-02 ,pp. : 10-20

Informa Healthcare

Access to resources Recommend Favorite

Predicting Intestinal Precipitation—A Case Example for a Basic BCS Class II Drug

By Carlert Sara   Pålsson Anna   Hanisch Gunilla   Corswant Christian   Nilsson Catarina   Lindfors Lennart   Lennernäs Hans   Abrahamsson Bertil  

Pharmaceutical Research, Vol. 27, Iss. 10, 2010-10 ,pp. : 2119-2130

Springer Publishing Company

Access to resources Recommend Favorite

Investigation of Drug Release from PEO Tablet Matrices in the Presence of Vitamin E as Antioxidant

By  

Current Drug Delivery, Vol. 12, Iss. 5, 2015-10 ,pp. : 591-599

Bentham Science Publishers

Access to resources Recommend Favorite